Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Clinical trial NCT00731224 · COMPLETED
Trial details
- NCT number
- NCT00731224
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.